Get the app!
Back to Companies

Lineage Cell Therapeutics, Inc.

LCTXNYSECIK: 0000876343

Over the 13 most recent insider filings, Lineage Cell Therapeutics, Inc. (LCTX) has seen activity from 9 distinct insiders — all of them on the buy side. The activity is heavily weighted toward buying: $895.4K bought versus $0 sold, a net purchase of $895.4K. BROADWOOD PARTNERS, L.P. (Director, 10% Owner) is the most active by dollar volume, and the single largest transaction was $770.7K by BROADWOOD PARTNERS, L.P.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$1.7M
Purchases
$895.4K
Sales
$0
Unique Insiders
9

Recent Insider Trades

13 loaded
Nov 19LCTX
Lineage Cell Therapeutics, Inc.
BROADWOOD PARTNERS, L.P.Director, 10% OwnerBuy$770.7K
Nov 19LCTX
Lineage Cell Therapeutics, Inc.
Mulroy Michael H.DirectorBuy$26.1K
Nov 17LCTX
Lineage Cell Therapeutics, Inc.
Culley Brian MInsiderBuy$37.1K
Nov 16LCTX
Lineage Cell Therapeutics, Inc.
Howe Jill AnnInsiderBuy$17.1K
Nov 17LCTX
Lineage Cell Therapeutics, Inc.
ANDREWS DEBORAH JInsiderBuy$20.0K
Jul 2LCTX
Lineage Cell Therapeutics, Inc.
Russell Angus C.InsiderAward$162.5K
Jul 2LCTX
Lineage Cell Therapeutics, Inc.
Bradsher Neal CDirector, 10% OwnerAward$162.5K
Jul 2LCTX
Lineage Cell Therapeutics, Inc.
Jayasuriya AnulaInsiderAward$162.5K
Jul 2LCTX
Lineage Cell Therapeutics, Inc.
ANDREWS DEBORAH JInsiderAward$162.5K
Jul 2LCTX
Lineage Cell Therapeutics, Inc.
Mulroy Michael H.InsiderAward$162.5K
Mar 12LCTX
Lineage Cell Therapeutics, Inc.
Culley Brian MInsiderBuy$24.4K
Dec 19LCTX
Lineage Cell Therapeutics, Inc.
Samuel George A. IIIInsiderGrant$109
Dec 19LCTX
Lineage Cell Therapeutics, Inc.
Culley Brian MInsiderGrant$561

13 filings